Activities

This video-based program is designed for eye care professionals to explore the management of neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) using newer anti-VEGF agents with the potential for extended treatment intervals. This program places the patient’s...

Activity Overview This on-demand video program features expert faculty in the field of psoriasis who review the consensus statement from the National Psoriasis Foundation (NPF) regarding on-treatment remission in plaque psoriasis (PsO). The faculty discuss definitions, the methodology for the...

This online, on-demand virtual symposium brings together renowned experts in glaucoma. In this educational program, these experts focus on interventional glaucoma, a more proactive management approach that aims to minimize the challenges associated with topical glaucoma management with the earlier...

In this online, on-demand educational video, Gus Alva, MD, DFAPA; and Erin Crown, MHS, PA-C will discuss the utility of oral antipsychotics for the treatment of newly diagnosed and previously treated patients with schizophrenia. The expert faculty will review the...

Research revealing that overexpression of TL1A drives key pathological pathways in inflammatory bowel disease (IBD) has accelerated the development of biologic therapies aimed at inhibiting this ligand. Early studies of investigational anti-TL1A agents—including tulisokibart, afimkibart, and duvakitug—demonstrate encouraging outcomes in...

This educational activity is an archive of the live presentation held on February 12, 2026. For more information about this educational activity, the faculty, and disclosures, please click here. Target Audience This educational activity is directed toward rheumatologists, nurse practitioners,...

Recent advances in the treatment of presbyopia have focused on pharmacological agents as a novel therapeutic strategy that offers noninvasive, reversible options capable of enhancing depth of focus without altering the natural lens structure. As new and emerging pharmacological therapies...

This online, on-demand virtual symposium brings together renowned experts in paroxysmal nocturnal hemoglobinuria (PNH). In this educational program, these experts engage in an in-depth exploration of PNH, with a focus on pathophysiology and disease burden, clinical manifestations, best practices for...

For patients with sickle cell disease (SCD), the transition from pediatric to adult care is a high-risk period that is often marked by gaps in care and worsening outcomes. This educational program brings together experienced hematologists to share data, clinical...

Sickle cell disease (SCD) has entered a transformative era marked by significant progress in disease-modifying therapy (DMT) and curative strategies. This educational program brings together leading SCD experts to explore the latest evidence, real-world insights, and clinical considerations shaping modern...